VentiRx Pharmaceuticals Inc. — Form D/A
VentiRx Pharmaceuticals Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2014-09-23. The offering totals $53.1M, of which $50.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-09-23
- Form: D/A
- Accession: 0001367762-14-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $53.1M
- Amount sold: $50.6M
- Remaining: $2.5M
- Investors: 9
- Date of first sale: 2010-01-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-91597
Issuer
- Name: VentiRx Pharmaceuticals Inc.
- CIK: 0001367762
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2006
- Address: 1191 SECOND AVE., SEATTLE, WA, 98101
- Phone: (206) 689-2259
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Patrick M Heron | Director | Carmel, IN |
| Michael J Kamdar | Director | San Diego, CA |
| Michael J Kamdar | Executive Officer | San Diego, CA |
| Patrick J Heron | Director | Menlo Park, CA |
| Nicole M Vitullo | Director | Radnor, PA |
| Nicole J Vitullo | Director | Menlo Park, CA |
| Ron M Laufer | Director | Gaithersburg, MD |
| Atul M Saran | Director | Seattle, WA |
| Kathleen M Fanning | Executive Officer | Seattle, WA |
| Robert M Hershberg, M.D., Ph.D. | Director | Seattle, WA |
| Robert M Hershberg, M.D., Ph.D. | Executive Officer | Seattle, WA |
| Kent M Snyder | Director | Seattle, WA |
| Steven M Gillis, Ph.D. | Director | Seattle, WA |
| Elliot M Grossbard, M.D. | Director | Seattle, WA |
| Maggie Flanagan LeFlore, Ph.D. | Director | Gaithersburg, MD |
| Elliot J Grossbard, M.D. | Director | San Diego, CA |
| Kent Flanagan Snyder | Director | San Diego, CA |
| Steven J Gillis, Ph.D. | Director | Mercer Island, WA |
Other filings by this issuer (3)
More